AO

Abhijit Ojha

Active Director Director DIN 07074342
DIN 07074342 First appointment Jun 2015 Primary industry Pharma
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Jun 2015
Shareholding value •••• Premium profile

About Abhijit Ojha

Data last updated:

Abhijit Ojha is a Director at Amicizia Life Science Private Limited (since 2015). The company operates in Pharma. Amicizia Life Science Private Limited reported revenue of ₹2.29 Cr (FY 2025).

DIN 07074342
Primary Designation Director
Industry Pharma
First Appointment 05 Jun 2015
Oldest Company Age 11 yrs
Largest company Amicizia Life Science Private Limited · ₹2.29 Cr (FY 2025)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director05 Jun 20152015₹2.29 Cr (FY 2025)Active

Board colleagues of Abhijit Ojha

NameDINCompanyDesignation
Shamita Ojha07074383Amicizia Life Science Private LimitedDirector

Directorship timeline

Open interactive timeline →
Amicizia Life Science Private Limited
Premium access

Shareholding and investment profile for Abhijit Ojha

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Abhijit Ojha

Abhijit Ojha currently holds 1 directorship: Amicizia Life Science Private Limited (Director, since 05 Jun 2015, revenue ₹2.29 Cr (FY 2025)).

Abhijit Ojha was first appointed on 05 Jun 2015 as Director at Amicizia Life Science Private Limited.

The current boards of Abhijit Ojha's companies include Shamita Ojha (Amicizia Life Science Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available